Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
TARGET-AUTOIMMUNE is an observational research study to conduct a comprehensive review of outcomes for patients with autoimmune and related diseases. .
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Disease Cohort | Observational | ||
| Engaged Cohort | Observational |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To characterize the natural history of disease in patients with autoimmune disease of various etiologies. | 15 Years | |
| To assess safety and effectiveness of autoimmune disease treatments and treatments for complications of any related conditions | 20 Years |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate provider management practices in the treatment of patients with autoimmune diseases | Health care provider type, clinic setting, reason for initiating/not initiating/adjusting dosing of treatments, reason for discontinuing/switching treatments, and monitoring outcomes on and off treatment, will be captured as available in the provided EHR and/or through linked data. Disease-specific quality measures will be selected and evaluated. |
Not provided
Disease Cohort
Inclusion Criteria:
- Adult patients at the time of enrollment with a diagnosis autoimmune disease by select ICD-10 codes in the EHR interface
Exclusion Criteria:
Engaged Cohort
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The study will include adults who are being managed for autoimmune disease
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001327 | Autoimmune Diseases |
| ID | Term |
|---|---|
| D007154 | Immune System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Whole blood and serum
| 15 Years |
| To evaluate longitudinal and patient reported outcomes in patients with autoimmune diseases | Longitudinal clinical outcomes and disease progression will be assessed. Self-reported patient health measures collect information directly from patients to measure physical, mental, and social health. These measures can help clinicians better understand how the disease state and/or various treatments affect what patients are able to do and the symptoms they experience beyond what is typically derived and reported in the EHR as part of traditional clinical evaluations. The information can also be used to help patients make informed decisions about their healthcare and treatment options. | 15 Years |
| To select and evaluate quality of care measures for patients with autoimmune diseases |
| 15 Years |